임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
52건 표시
- 3상모집 예정· Glabellar LinesEvaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar Lines
리드: 대웅제약
- 3상완료· Essential HypertensionA Phase III Study to Efficacy and Safety of DWC202405/DWC202313 and DWC202314 in Patients With Hypertension
리드: 대웅제약
- 3상완료· HypertensionEfficacy and Safety of DWC202404 and DWC202314 in Patients With Hypertension
리드: 대웅제약
- 3상완료· Gastro Oesophageal Reflux DiseaseStudy Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Disease
협력: 대웅제약
- 3상모집 예정· Type 2 Diabetic NephropathyEvaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Patients
리드: 대웅제약
- 3상완료· Helicobacter Pylori InfectionStudy to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori
리드: 대웅제약
- 3상상태 미확인· T2DM (Type 2 Diabetes Mellitus)Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus
리드: 대웅제약
- 3상모집 중단 (진행 중)· Tricuspid RegurgitationEnavogliflozin Outcome Trial in Functional Tricuspid Regurgitation
협력: 대웅제약
- 3상상태 미확인· Non-erosive Reflux DiseaseStudy to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD)
리드: 대웅제약
- 3상상태 미확인· Type 2 Diabetes MellitusA Study to Investigate the Effect of DWP16001 as add-on Therapy to Drug A in Patients With Type 2 Diabetes Mellitus
리드: 대웅제약
- 3상상태 미확인· Diabetes MellitusThe Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin
리드: 대웅제약
- 3상완료· Reflux EsophagitisThe Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis
리드: 대웅제약
- 3상완료· T2DM (Type 2 Diabetes Mellitus)Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM.
리드: 대웅제약
- 3상완료· T2DM (Type 2 Diabetes Mellitus)Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin
리드: 대웅제약
- 3상조기 종료· Severe COVID-19Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients
리드: 대웅제약
- 3상완료· T2DM (Type 2 Diabetes Mellitus)The Efficacy Nad Safety of DWP16001 Compared to Active Drug in the Treatment of Type 2 Diabetes Mellitus
리드: 대웅제약
- 3상완료· T2DM (Type 2 Diabetes Mellitus)The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes.
리드: 대웅제약
- 3상완료· T2DM (Type 2 Diabetes Mellitus)The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus.
리드: 대웅제약
- 3상완료· Moderate to Severe Glabellar LinesDWP450 for Treating Moderate to Severe Glabellar Lines
리드: 대웅제약
- 3상상태 미확인· Healed Erosive EsophagitisStudy to Evaluate the Efficacy and Safety of DWP14012 on Maintaining Healing in Subjects With Healed Erosive Esophagitis
리드: 대웅제약
- 3상완료· Acute GastritisStudy to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis
리드: 대웅제약
- 3상완료· Benign Masseteric HypertrophyEfficacy and Safety of DWP450 in Subjects With Benign Masseteric Hypertrophy
리드: 대웅제약
- 3상상태 미확인· Hypertension, DyslipidemiaClinical Trail to Evaluate the Efficacy and Safety of DWJ1451
리드: 대웅제약
- 3상완료· Submental FatEvaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat
리드: 대웅제약
- 3상상태 미확인· Non-Erosive Gastroesophageal Reflux DiseaseStudy to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non Erosive Reflux Disease
리드: 대웅제약
- 3상조기 종료· GastritisEfficacy and Safety of DWC20155/DWC20156 Combination Therapy in Patients With Gastritis
리드: 대웅제약
- 3상상태 미확인· Crow's Feet LinesEfficacy and Safety of DWP450 for Treating Crows Feet Lines(CFL) in Combination With Glabellar Lines(Extension Study)
리드: 대웅제약
- 3상완료· Functional DyspepsiaEfficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2)
리드: 대웅제약
- 3상완료· Functional DyspepsiaEfficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia
리드: 대웅제약
- 3상상태 미확인· Patients With Thyroidecomy (Scheduled)Clinical Trail to Evaluate the Efficacy and Safety of Adhesion Barrier Mediclore Versus no Treatment in Patients With Total Thyroidectomy
리드: 대웅제약
- 3상완료· Type II DiabetesMetformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3)
리드: 대웅제약
- 3상상태 미확인· HypertensionEffect of Renal Denervation in End Staged Renal Disease With Resistant Hypertension
협력: 대웅제약
- 3상완료· HypertensionClinical Study for Patients With Hypertension Associated With Dyslipidemia
리드: 대웅제약
- 3상완료· Moderate to Severe Glabellar LineEfficacy and Safety of DWP450 Compared With Botox in Moderate to Severe Glabellar Line
리드: 대웅제약
- 3상완료· Diabetic Foot Ulcer Patients With Uncontrolled Diabetes MellitusEfficacy and Safety of rhEGF in Diabetic Foot Ulcer Patients With Uncontrolled Diabetic Mellitus
리드: 대웅제약
- 3상완료· Regeneration of Alveolar Tissue After Maxillary Sinus Floor AugmentationEfficacy and Safety of Bongros-BMP Compared to Bio-oss for Regeneration of Alveolar Bone Tissue After Maxillary Sinus Floor Augmentation
리드: 대웅제약
- 3상완료· Growth Hormone DeficiencyEvaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency
리드: 대웅제약
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.